Literature DB >> 31127790

The Relationship Between the Use of Antihypertensive Drugs and the Incidence of Dementia in General Practices in Germany.

Jens Bohlken1, Louis Jacob2, Karel Kostev3.   

Abstract

BACKGROUND: In recent years, there has been a growing interest in the association between the use of antihypertensive drugs and the incidence of dementia.
OBJECTIVE: The goal of this retrospective study was to investigate the relationship between antihypertensive drug use and dementia in elderly persons followed in general practices in Germany.
METHODS: This study included patients ≥60 years with documented blood pressure values who were diagnosed with dementia in general practices in Germany for the first time between 2013 and 2017 (index date). Dementia cases were matched to non-dementia controls using propensity scores based on age, sex, index year, and co-diagnoses. The main outcome of the study was the incidence of dementia as a function of the use of antihypertensive drugs.
RESULTS: The present study included 12,405 patients with dementia and 12,405 patients without dementia. The use of angiotensin II receptor blockers (odds ratios [ORs] ranging from 0.74 to 0.79), angiotensin-converting enzyme inhibitors (ORs ranging from 0.85 to 0.88), calcium channel blockers (ORs ranging from 0.82 to 0.89), and beta blockers (OR = 0.88) was associated with a decrease in dementia incidence.
CONCLUSION: Antihypertensive drug use is negatively associated with dementia in elderly persons followed in general practices in Germany.

Entities:  

Keywords:  Antihypertensive drugs; Germany; dementia; elderly persons; general practices

Year:  2019        PMID: 31127790     DOI: 10.3233/JAD-190362

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study.

Authors:  Danique R Hutten; Jens H J Bos; Stijn de Vos; Eelko Hak
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Treatment Patterns of Patients with All-Cause Dementia in Russia.

Authors:  Karel Kostev; Galina Osina
Journal:  J Alzheimers Dis Rep       Date:  2020-01-25

3.  The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.

Authors:  Michael Ouk; Che-Yuan Wu; Jennifer S Rabin; Aaron Jackson; Jodi D Edwards; Joel Ramirez; Mario Masellis; Richard H Swartz; Nathan Herrmann; Krista L Lanctôt; Sandra E Black; Walter Swardfager
Journal:  Alzheimers Res Ther       Date:  2021-02-11       Impact factor: 6.982

Review 4.  Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.

Authors:  Noemi Esteras; Andrey Y Abramov
Journal:  Cells       Date:  2020-09-21       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.